These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11468876)

  • 1. An evaluation of the use of proton pump inhibitors.
    Walker NM; McDonald J
    Pharm World Sci; 2001 Jun; 23(3):116-7. PubMed ID: 11468876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validity of proton pump inhibitors' prescriptions in a department of internal medicine].
    Marie I; Moutot A; Tharrasse A; Hellot MF; Robaday S; Hervé F; Lévesque H
    Rev Med Interne; 2007 Feb; 28(2):86-93. PubMed ID: 17092611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overuse of PPIs in patients at admission, during treatment, and at discharge in a tertiary Spanish hospital.
    Ramirez E; Lei SH; Borobia AM; Piñana E; Fudio S; Muñoz R; Campos A; Carcas AJ; Frias J
    Curr Clin Pharmacol; 2010 Nov; 5(4):288-97. PubMed ID: 20925644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
    Luo H; Fan Q; Xiao S; Chen K
    BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of use of proton pump inhibitors in Greece.
    Ntaios G; Chatzinikolaou A; Kaiafa G; Savopoulos C; Hatzitolios A; Karamitsos D
    Eur J Intern Med; 2009 Mar; 20(2):171-3. PubMed ID: 19327607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance between use of proton pump inhibitors and prescribing guidelines.
    Pillans PI; Kubler PA; Radford JM; Overland V
    Med J Aust; 2000 Jan; 172(1):16-8. PubMed ID: 10682010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reasons for initiation of proton pump inhibitor therapy for hospitalised patients and its impact on outpatient prescription in primary care.
    Villamañán E; Ruano M; Lara C; Suárez-de-Parga JM; Armada E; Álvarez-Sala R; Pérez E; Herrero A
    Rev Esp Enferm Dig; 2015 Nov; 107(11):652-8. PubMed ID: 26541654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why do GPs continue inappropriate hospital prescriptions of proton pump inhibitors? A qualitative study.
    Wermeling M; Himmel W; Behrens G; Ahrens D
    Eur J Gen Pract; 2014 Sep; 20(3):174-80. PubMed ID: 24219345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increased prescribing of proton pump inhibitors in ambulatory care over the years 2005 - 2013].
    Hoffmann F; Glaeske G; Schmiemann G
    Z Gastroenterol; 2015 Feb; 53(2):95-100. PubMed ID: 25251751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards.
    van Vliet EP; Otten HJ; Rudolphus A; Knoester PD; Hoogsteden HC; Kuipers EJ; Siersema PD
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):608-12. PubMed ID: 18679061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriateness of gastric antisecretory therapy in hospital practice.
    Sebastian SS; Kernan N; Qasim A; O'Morain CA; Buckley M
    Ir J Med Sci; 2003; 172(3):115-7. PubMed ID: 14700112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General practice variation when initiating long-term prescribing of proton pump inhibitors: a nationwide cohort study.
    Haastrup PF; Rasmussen S; Hansen JM; Christensen RD; Søndergaard J; Jarbøl DE
    BMC Fam Pract; 2016 May; 17():57. PubMed ID: 27233634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium.
    Fraeyman J; Van Hal G; Godman B; Beutels P
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):141-51. PubMed ID: 23402454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irrational use of proton pump inhibitors in general practise.
    Ali O; Poole R; Okon M; Maunick S; Troy E
    Ir J Med Sci; 2019 May; 188(2):541-544. PubMed ID: 30136221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitor co-prescription with dual antiplatelet therapy among patients with acute coronary syndrome in Qatar.
    Awaisu A; Hamou F; Mekideche L; El Muabby N; Mahfouz A; Mohammed S; Saad A
    Int J Clin Pharm; 2016 Apr; 38(2):353-61. PubMed ID: 26749343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost and cost-effectiveness of PPIs--GP perspectives and responses to a prescribing dilemma and their implications for the development of patient-centred healthcare.
    Pollock K; Grime J
    Eur J Gen Pract; 2003 Dec; 9(4):126-33, 140. PubMed ID: 14733400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors: a study of GPs' prescribing.
    Jones MI; Greenfield SM; Jowett S; Bradley CP; Seal R
    Fam Pract; 2001 Jun; 18(3):333-8. PubMed ID: 11356744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self-regulation of treatment may be an under-exploited resource.
    Pollock K; Grime J
    Soc Sci Med; 2000 Dec; 51(12):1827-39. PubMed ID: 11128270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate use of proton pump inhibitors in a local setting.
    Chia CT; Lim WP; Vu CK
    Singapore Med J; 2014 Jul; 55(7):363-6. PubMed ID: 25091884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.